showed a trendp=0.13
Patients <55 also showed a trend towards an increased risk of death with a HR of 1.49 (p=0.13).
Patients <55 also showed a trend towards an increased risk of death with a HR of 1.49 (p=0.13).
21 Patients who were <55 at the time of diagnosis showed an unexpected trend towards worse survival (5.5 yrs versus 7.8 yrs) despite having fewer comorbidities and a better performance status.
This group developed bone metastases earlier, a result that bordered on being statistically significant.